Safty and Efficacy of MCI Network Guided TMS for Early Alzheimer's Disease: A Randomized, Double-blind Trial
RecruitingNCT07138677Phase: NAStarted 2025-07-20
Summary
Estimate the safty and efficacy of personalized network neuronavigated transcranial magnetic stimulations in early Alzheimer's disease patients
Eligibility
Sex
ALL
Min Age
45 Years
Max Age
85 Years
Locations
Anhui Medical UniversityHefei, Anhui, China
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT07138677